CD8A and neoplasm: Finally, Hwang HS et al. showed that CD8+ T-cell function induced by PDT combined with peptide vaccination of a tumor-specific TLR5 agonist can be significantly enhanced by PD-1 checkpoint inhibitor therapy [122].